Link, Andreas	34978
Evaluation of (S)- and (R)-misonidazole as GPX inhibitors: synthesis, characterization including circular dichroism and in vitro testing on bovine GPx-1
Microwave-assisted synthesis and evaluation of acylhydrazones as potential inhibitors of bovine glutathione peroxidase
4-Aminocyclopentane-1,3-diols as platforms for diversity: synthesis of a screening library
Oxidation Potentials of N-Modified Derivatives of the Analgesic Flupirtine Linked to Potassium KV7 Channel Opening Activity But Not Hepatocyte Toxicity
Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.
Three-Component Aminoalkylations Yielding Dihydronaphthoxazine-Based Sirtuin Inhibitors: Scaffold Modification and Exploration of Space for Polar Side-Chains
Synthesis, chemical behavior, structure elucidation and iNOS inhibitory activity of 1-substituted 3-methylsulfanyl-5,6,7,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazines+
Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection
Substituted tetrazoles as multipurpose screening compounds
G-Protein-Coupled Receptors: Sustained Signaling via Intracellular Megaplexes and Pathway-Specific Drugs
Tetrazolylhydrazides as Selective Fragment-Like Inhibitors of the JumonjiC-Domain-Containing Histone Demethylase KDM4A
Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform
Supercritical fluid extraction (SFE) of ketamine metabolites from dried urine and on-line quantification by supercritical fluid chromatography and single mass detection (on-line SFESFCMS)
Subcritical Fluid Chromatography at Sub-Ambient Temperatures for the Chiral Resolution of Ketamine Metabolites with Rapid-Onset Antidepressant Effects
Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators
Flupirtine Analogues: Explorative Synthesis and Influence of Chemical Structure on KV  7.2/KV  7.3 Channel Opening Activity
Supercritical fluid chromatography
Sulfide Analogues of Flupirtine and Retigabine with Nanomolar K  V  7.2/K  V  7.3 Channel Opening Activity
Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin Inhibitors
Synthesis and potassium KV7 channel opening activity of thioether analogues of the analgesic flupirtine
Replica-Based Protein Structure Sampling Methods II: Advanced Hybrid Solvent TIGER2hs
Crystal structure of 7,8,15,16,17-pentathiadispiro[5.2.59.36]heptadecane
Interconnection of sulfides and sulfoxides in medicinal chemistry
Crystal structure of benzo[h]quinoline-3-carboxamide
Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations.
Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects.
Activation of Sirtuin 2 Inhibitors Employing Photoswitchable Geometry and Aqueous Solubility
Near-infrared spectroscopic identification and quantification of active pharmaceutical ingredients in closed capsules: a feasibility study for pediatric doses
Simultaneous quantification of acidic and basic flupirtine metabolites by supercritical fluid chromatography according to European Medicines Agency validation
Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases
A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
Supercritical fluid extraction-supercritical fluid chromatography of saliva: Single-quadrupole mass spectrometry monitoring of caffeine for gastric emptying studies.
Nuclear import of BCL11B is mediated by a classical nuclear localization signal and not the Krüppel-like zinc fingers
Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors
Flucytosine?based prodrug activation by cold physical plasma
Cold Physical Plasma-Mediated Fenretinide Prodrug Activation Confers Additive Cytotoxicity in Epithelial Cells